Stonepine Capital Management, LLC
Q3 2025 13F-HR Holdings
Net value change ($000)
+21,080
(20.7%)
New positions
19
Sold out positions
19
Turnover %
26.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VSTM | 17,930 | 317.6% |
| XFOR | 3,613 | NEW |
| NKTR | 3,540 | 272.9% |
| OABIW | 3,429 | NEW |
| ABEO | 2,125 | 830.1% |
| EDSA | 1,698 | NEW |
| DAWN | 1,639 | 56.0% |
| SLNO | 1,622 | NEW |
| PMVP | 1,021 | 113.8% |
| EOLS | 992 | 11.8% |
Top Reduces (Value $000, Stocks/ETFs)
| iTeos Therapeutics, Inc. | -3,091 | -100.0% |
| ADMA | -2,824 | -20.7% |
| INDV | -2,748 | -53.3% |
| ANIP | -2,518 | -100.0% |
| ANIK | -2,016 | -100.0% |
| Y-mAbs Therapeutics, Inc. | -1,287 | -100.0% |
| COLL | -1,227 | -100.0% |
| KALV | -1,131 | -100.0% |
| ACAD | -1,128 | -23.2% |
| ARDX | -1,074 | -49.4% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|